Advertisement

Promoting Adult Immunization Using Population-Based Data for a Composite Measure

      Introduction

      A composite adult immunization status measure is currently under consideration for adoption into the Healthcare Effectiveness Data and Information Set. This paper complements the Healthcare Effectiveness Data and Information Set health plan–level measure testing efforts by examining use of survey-based self-reported vaccination data to assess composite adult immunization coverage and identify limitations to using survey data to measure progress.

      Methods

      The 2015 National Health Interview Survey data were used in 2017 to calculate estimates for a composite of selected vaccines routinely recommended for adults aged ≥19 years, overall and in three age groups: 19–59, 60–64, and ≥65 years for tetanus and diphtheria toxoids (Td); tetanus toxoid; reduced diphtheria toxoid; and tetanus, diphtheria, acellular pertussis vaccine (Tdap); and herpes zoster, pneumococcal, and influenza vaccines.

      Results

      Composite coverage for adults aged ≥19 years including receipt of Tdap in the past 10 years and influenza vaccination was 11.9%, ranging from 6.3% in adults aged 60–64 years to 13.7% in adults aged 19–59 years. Excluding influenza, composite coverage was 20.7%, ranging from 8.1% (adults aged 60–64 years) to 25.2% (adults aged 19–59 years). In a composite including any Td-containing vaccine in the past 10 years, coverage including influenza vaccination for adults aged ≥19 years was 23.4%, ranging from 12.6% (adults aged 60–64 years) to 25.7% (adults aged 19–59 years). Excluding influenza, composite coverage was 51.4%, ranging from 15.8% (adults aged 60–64 years) to 63.0% (adults aged 19–59 years).

      Conclusions

      Survey-based vaccination data may under- or over-estimate coverage, but most adults require at least one additional vaccination by any metric. A composite measure provides a single focal point to promote adherence to standards of care.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Kim DK
        • Riley LE
        • Harriman KH
        • et al.
        Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older—United States, 2017.
        MMWR Morb Mortal Wkly Rep. 2017; 66: 136-138
      1. Recommended immunization schedules for adults. CDC. www.cdc.gov/vaccines/schedules/hcp/adult.html. Updated February 27, 2017. Accessed July 18, 2017.

        • Williams WW
        • Lu P
        • O'Halloran A
        • et al.
        Surveillance of vaccination coverage among adult populations—United States, 2015.
        MMWR Surveill Summ. 2017; 66: 1-28
      2. Healthy People immunization and infectious diseases objectives. HHS. www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives. Updated July 18, 2017. Accessed July 19, 2017.

      3. Advance Notice of Methodological Changes for Calendar Year (CY) 2019 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2019 draft Call Letter. Centers for Medicare & Medicaid Services. www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Advance2019Part2.pdf. Accessed March 20, 2018.

        • Community Preventive Services Task Force
        The guide to community preventive services. Vaccination—Task Force findings.
        CDC, Atlanta, GA2018 (Accessed March 30,)
      4. Composite Performance Measure Evaluation Guidance. Washington, DC: National Quality Forum. www.qualityforum.org/Publications/2013/04/Composite_Performance_Measure_Evaluation_Guidance.aspx. Published 2013. Accessed July 13, 2017.

      5. Children's Health Care Quality Measures: 2017 Child Core Set. Centers for Medicare and Medicaid Services. www.medicaid.gov/medicaid/quality-of-care/performance-measurement/child-core-set/index.html. Accessed June 20, 2017.

      6. Priority Setting for Healthcare Performance Measurement: Addressing Performance Measure Gaps for Adult Immunizations. Washington, DC: National Quality Forum. www.qualityforum.org/Publications/2014/08/Priority_Setting_for_Healthcare_Performance_Measurement__Addressing_Performance_Measure_Gaps_for_Adult_Immunizations.aspx. Published 2014. Accessed June 20, 2017.

        • Gellin BG
        • Shen AK
        • Fish R
        • et al.
        The national adult immunization plan.
        Am J Prev Med. 2016; 51: 1079‒1083
      7. HEDIS® and Performance Measurement. National Committee for Quality Assurance website. www.ncqa.org/hedis-quality-measurement. Accessed March 30, 2018.

      8. National Early-Season Flu Vaccination Coverage, United States, November 2016. CDC. www.cdc.gov/flu/fluvaxview/nifs-estimates-nov2016.htm. Accessed July 17, 2017.

        • Lu PJ
        • O'Halloran A
        • Ding H
        • Williams WW
        • Bridges CB
        • Kennedy ED
        National and state-specific estimates of place of influenza vaccination among adult populations—United States, 2011‒12 influenza season.
        Vaccine. 2014; 32: 3198‒3204
        • Islam JY
        • Gruber JF
        • Lockhart A
        • et al.
        Opportunities and challenges of adolescent and adult vaccination administration within pharmacies in the United States.
        Biomed Inform Insights. 2017; 9: 1‒10
        • Hurley LP
        • Bridges CB
        • Harpaz R
        • et al.
        U.S. physicians’ perspective of adult vaccine delivery.
        Ann Intern Med. 2014; 160: 161‒170
        • Tomczyk S
        • Bennett MN
        • Stoecker C
        • et al.
        Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Morb Mortal Wkly Rep. 2014; 63: 822‒825
        • Kobayashi M
        • Bennett NM
        • Gierke R
        • et al.
        Intervals between PCV13 and PPSV23 vaccines: recommendations of the advisory committee on immunization practices (ACIP).
        MMWR Morb Mortal Wkly Rep. 2015; 64: 944‒947
        • CDC
        Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Morb Mortal Wkly Rep . 2012; 61: 816-819
      9. NHIS Data, Questionnaires and Related Documentation. CDC. www.cdc.gov/nchs/nhis/data-questionnaires-documentation.htm. Updated March 12, 2018. Accessed March 30, 2018.

        • Black CL
        • Williams WW
        • Warnock R
        • Pilishvili T
        • Kim D
        • Kelman JA
        Pneumococcal vaccination among Medicare beneficiaries occurring after the Advisory Committee on Immunization Practices recommendation for routine use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults aged ≥65 years.
        MMWR Morb Mortal Wkly Rep. 2017; 66: 728-733
        • Rolnick SJ
        • Parker ED
        • Nordin JD
        • et al.
        Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?.
        Vaccine. 2013; 31: 3928-3935
        • Mac Donald R
        • Baken L
        • Nelson A
        • Nichol KL
        Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients.
        Am J Prev Med. 1999; 16: 173-177
        • Mangtani P
        • Shah A
        • Roberts JA
        Validation of influenza and pneumococcal vaccine status in adults based on self-report.
        Epidemiol Infect. 2007; 135: 139-143
        • Zimmerman RK
        • Raymund M
        • Janosky JE
        • Nowalk MP
        • Fine MJ
        Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata.
        Vaccine. 2003; 21: 1486-1491
        • National Vaccine Advisory Committee
        Recommendations from the National Vaccine Advisory Committee: Standards for adult immunization practice.
        Public Health Rep . 2014; 129: 115‒123
        • Appleby J
        • Hodin M
        • Satcher D
        • et al.
        The value and imperative of quality measures for adult vaccines.
        Adult Vaccine Access Coalition, Washington, DC2017 (Published 2016. Accessed June 20,)

      Linked Article

      • Correction
        American Journal of Preventive MedicineVol. 56Issue 2
        • Preview
          Angela K. Shen, MPH, Walter W. Williams, MD, MPH, Alissa C. O'Halloran, MSPH, Amy V. Groom, MPH, Peng-Jun Lu, MD, PhD, Alice Y. Tsai, MPH, Megan C. Lindley, MPH. Promoting Adult Immunization Using Population-Based Data for a Composite Measure. Am J Prev Med. 2018:55(4):517–523.
        • Full-Text
        • PDF